Subscribe to RSS
DOI: 10.1055/a-2779-5052
Nonpharmacological Strategies to Improve Stability and Prevent Exacerbations of COPD
Authors
Funding Information This work was supported by the “Ricerca Corrente” Funding scheme of the Ministry of Health, Italy.
Abstract
Exacerbations of chronic obstructive pulmonary disease (ECOPD) are the main cause of hospitalization, mortality, and progressive worsening in health-related quality of life (HRQL). Each ECOPD speeds functional decline, making these individuals increasingly susceptible to further infections. Therefore, we need strategies to prevent ECOPD and maintain disease stability as long as possible. In addition to medications, lifestyle interventions aimed at promoting vaccinations and avoiding smoking, minimizing exposure to environmental pollutants, encouraging physical activity, addressing obesity and malnutrition, along with empowering individuals through disease awareness and self-management, may improve stability and HRQL and reduce ECOPD rate. Although long-term oxygen therapy is known to enhance survival, its broader utility in curtailing healthcare utilization requires further clarification. Home noninvasive ventilation (NIV) and the more recently introduced high-flow nasal cannula may reduce the need for hospitalization and mortality in individuals with stable chronic hypercapnia. Long-term NIV should be initiated after ECOPD is successfully treated and set to reduce hypercapnia. Telemedicine programs may be potentially useful, but their effectiveness and safety in real life have to be confirmed.
Keywords
dyspnea - exacerbation - long-term oxygen therapy - noninvasive ventilation - quality of life - survivalContributors' Statement
M.V.: conceptualization, visualization, writing—original draft, writing—review and editing; N.A.: writing—original draft, writing—review and editing.
Publication History
Received: 24 June 2025
Accepted: 27 December 2025
Article published online:
05 March 2026
© 2026. Thieme. All rights reserved.
Thieme Medical Publishers, Inc.
333 Seventh Avenue, 18th Floor, New York, NY 10001, USA
-
References
- 1 Global Initiative for Chronic Obstructive Lung Disease. 2025 GOLD report: global strategy for prevention, diagnosis and management of COPD: 2025 report. Accessed May 17, 2025 at: https://goldcopd.org/2025-gold-report/
- 2 Singh D, Han MK, Bhatt SP. et al. Is disease stability an attainable chronic obstructive pulmonary disease treatment goal?. Am J Respir Crit Care Med 2025; 211 (03) 452-463
- 3 Kusunose M, Oga T, Nakamura S, Hasegawa Y, Nishimura K. Frailty and patient-reported outcomes in subjects with chronic obstructive pulmonary disease: are they independent entities?. BMJ Open Respir Res 2017; 4 (01) e000196
- 4 Ambrosino N, Bertella E. Lifestyle interventions in prevention and comprehensive management of COPD. Breathe (Sheff) 2018; 14 (03) 186-194
- 5 Agusti A, Ambrosino N, Blackstock F. et al. COPD: providing the right treatment for the right patient at the right time. Respir Med 2023; 207: 107041
- 6 Micheletto C, Aliberti S, Andreoni M. et al. Vaccination strategies in respiratory diseases: recommendation from AIPO-ITS/ETS, SIMIT, SIP/IRS, and SItI. Respiration 2025; 104 (08) 556-574
- 7 Micheletto C, Aliberti S, Andreoni M. et al; Associazione Italiana Pneumologi Ospedalieri - Italian Thoracic Society (AIPO-ITS/ETS), Società Italiana di Malattie Infettive e Tropicali (SIMIT), Società Italiana di Pneumologia/Italian Respiratory Society (SIP/IRS), Società Italiana di Igiene, Medicina Preventiva e Sanità Pubblica (SItI). Vaccination strategies in respiratory diseases: recommendation from AIPO-ITS/ETS, SIMIT, SIP/IRS, and SItI. Respiration 2025; 104 (08) 556-574
- 8 Mamun AA, Peeters A, Barendregt J, Willekens F, Nusselder W, Bonneux L. NEDCOM, The Netherlands Epidermiology and Demography Compression of Morbidity Research Group. Smoking decreases the duration of life lived with and without cardiovascular disease: a life course analysis of the Framingham Heart Study. Eur Heart J 2004; 25 (05) 409-415
- 9 GBD 2015 Chronic Respiratory Disease Collaborators. Global, regional, and national deaths, prevalence, disability-adjusted life years, and years lived with disability for chronic obstructive pulmonary disease and asthma, 1990–2015: a systematic analysis for the Global Burden of Disease Study 2015. Lancet Respir Med 2017; 5 (10) e30
- 10 Lim S, Lam DC, Muttalif AR. et al. Impact of chronic obstructive pulmonary disease (COPD) in the Asia-Pacific region: the EPIC Asia population-based survey. Asia Pac Fam Med 2015; 14 (01) 4
- 11 Bai JW, Chen XX, Liu S, Yu L, Xu JF. Smoking cessation affects the natural history of COPD. Int J Chron Obstruct Pulmon Dis 2017; 12: 3323-3328
- 12 Wang Z, Qiu Y, Ji X, Dong L. Effects of smoking cessation on individuals with COPD: a systematic review and meta-analysis. Front Public Health 2024; 12: 1433269
- 13 van Eerd EA, van der Meer RM, van Schayck OC, Kotz D. Smoking cessation for people with chronic obstructive pulmonary disease. Cochrane Database Syst Rev 2016; 2016 (08) CD010744
- 14 Malvi A, Khatib MN, Ganesan S. et al. Assessing the impact of electronic nicotine delivery systems on chronic obstructive pulmonary disease: a systematic review and meta-analysis. Respir Med 2025; 241: 108059
- 15 World Health Organization. Air Pollution. Accessed, May 19, 2025 at: https://www.who.int/health-topics/air-pollution
- 16 Brunekreef B, Strak M, Chen J. et al. Mortality and morbidity effects of long-term exposure to low-level PM2.5, BC, NO2, and O3: an analysis of European cohorts in the ELAPSE project. Res Rep Health Eff Inst 2021; 2021 (208) 1-127
- 17 Cullinan P, Muñoz X, Suojalehto H. et al. Occupational lung diseases: from old and novel exposures to effective preventive strategies. Lancet Respir Med 2017; 5 (05) 445-455
- 18 Wang C, Xu J, Yang L. et al; China Pulmonary Health Study Group. Prevalence and risk factors of chronic obstructive pulmonary disease in China (the China Pulmonary Health [CPH] study): a national cross-sectional study. Lancet 2018; 391 (10131): 1706-1717
- 19 Lee IM, Shiroma EJ, Lobelo F, Puska P, Blair SN, Katzmarzyk PT. Lancet Physical Activity Series Working Group. Effect of physical inactivity on major non-communicable diseases worldwide: an analysis of burden of disease and life expectancy. Lancet 2012; 380 (9838): 219-229
- 20 Althoff T, Sosič R, Hicks JL, King AC, Delp SL, Leskovec J. Large-scale physical activity data reveal worldwide activity inequality. Nature 2017; 547 (7663): 336-339
- 21 Waschki B, Kirsten AM, Holz O. et al. Disease progression and changes in physical activity in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2015; 192 (03) 295-306
- 22 Garcia-Aymerich J, Lange P, Benet M, Schnohr P, Antó JM. Regular physical activity reduces hospital admission and mortality in chronic obstructive pulmonary disease: a population based cohort study. Thorax 2006; 61 (09) 772-778
- 23 Garcia-Aymerich J, Lange P, Benet M, Schnohr P, Antó JM. Regular physical activity modifies smoking-related lung function decline and reduces risk of chronic obstructive pulmonary disease: a population-based cohort study. Am J Respir Crit Care Med 2007; 175 (05) 458-463
- 24 Mesquita R, Nakken N, Janssen DJA. et al. Activity levels and exercise motivation in patients with COPD and their resident loved ones. Chest 2017; 151 (05) 1028-1038
- 25 Watz H, Pitta F, Rochester CL. et al. An official European Respiratory Society statement on physical activity in COPD. Eur Respir J 2014; 44 (06) 1521-1537
- 26 Angelucci A, Canali S, Aliverti A. Digital technologies for step counting: between promises of reliability and risks of reductionism. Front Digit Health 2023; 5: 1330189
- 27 Vaz Fragoso CA, Beavers DP, Anton SD. et al; Lifestyle Interventions and Independence in Elders Investigators. Effect of structured physical activity on respiratory outcomes in sedentary elderly adults with mobility limitations. J Am Geriatr Soc 2016; 64 (03) 501-509
- 28 Cannon D, Buys N, Sriram KB, Sharma S, Morris N, Sun J. The effects of chronic obstructive pulmonary disease self-management interventions on improvement of quality of life in COPD patients: a meta-analysis. Respir Med 2016; 121: 81-90
- 29 Walters JA, Turnock AC, Walters EH, Wood-Baker R. Action plans with limited patient education only for exacerbations of chronic obstructive pulmonary disease. Cochrane Database Syst Rev 2010; (05) CD005074
- 30 Vauterin D, Van Vaerenbergh F, Grymonprez M, Vanoverschelde A, Lahousse L. Medication adherence to inhalation therapy and the risk of COPD exacerbations: a systematic review with meta-analysis. BMJ Open Respir Res 2024; 11 (01) e001964
- 31 Schols AM, Ferreira IM, Franssen FM. et al. Nutritional assessment and therapy in COPD: a European Respiratory Society statement. Eur Respir J 2014; 44 (06) 1504-1520
- 32 Gattermann Pereira T, Lima J, Silva FM. Undernutrition is associated with mortality, exacerbation, and poorer quality of life in patients with chronic obstructive pulmonary disease: a systematic review with meta-analysis of observational studies. J Parenter Enteral Nutr 2022; 46 (05) 977-996
- 33 Williamson A, Martineau AR, Jolliffe D. et al. Vitamin D for the management of chronic obstructive pulmonary disease. Cochrane Database Syst Rev 2024; 9 (09) CD013284
- 34 Lin P, Shen C, Li Q. et al. A systematic review and meta-analysis of chronic obstructive pulmonary disease in Asia: risk factors for readmission and readmission rate. BMC Pulm Med 2024; 24 (01) 388
- 35 Simon P, Török É, Szalontai K. et al. Nutritional support of chronic obstructive pulmonary disease. Nutrients 2025; 17 (07) 1149
- 36 Beijers RJHCG, Wouters EFM, Schols AMWJ. Nutritional management in pulmonary rehabilitation. In: Donner CF, Ambrosino N, Goldstein RS. Pulmonary Rehabilitation. 2nd ed.. CRC Press; 2020: 135-144
- 37 Paneroni M, Simonelli C, Vitacca M, Ambrosino N. Aerobic exercise training in very severe chronic obstructive pulmonary disease: a systematic review and meta-analysis. Am J Phys Med Rehabil 2017; 96 (08) 541-548
- 38 Jenkins AR, Burtin C, Camp PG. et al. Do pulmonary rehabilitation programmes improve outcomes in patients with COPD posthospital discharge for exacerbation: a systematic review and meta-analysis. Thorax 2024; 79 (05) 438-447
- 39 Meneses-Echavez JF, Chavez Guapo N, Loaiza-Betancur AF, Machado A, Bidonde J. Pulmonary rehabilitation for acute exacerbations of COPD: a systematic review. Respir Med 2023; 219: 107425
- 40 Vanfleteren LEGW, van 't Hul AJ, Kulbacka-Ortiz K, Andersson A, Ullman A, Ingvar M. Challenges to the application of integrated, personalized care for patients with COPD—a vision for the role of clinical information. J Clin Med 2020; 9 (05) 1311
- 41 Poot CC, Meijer E, Kruis AL, Smidt N, Chavannes NH, Honkoop PJ. Integrated disease management interventions for patients with chronic obstructive pulmonary disease. Cochrane Database Syst Rev 2021; 9 (09) CD009437
- 42 Pascoe A, Chen X, Smallwood N. A narrative review of proactive palliative care models for people with COPD. Ther Adv Respir Dis 2025; 19: 17 534666241310987
- 43 Spece LJ, Epler EM, Duan K. et al. Reassessment of home oxygen prescription after hospitalization for chronic obstructive pulmonary disease. A potential target for deimplementation. Ann Am Thorac Soc 2021; 18 (03) 426-432
- 44 Owens RL, Derom E, Ambrosino N. Supplemental oxygen and noninvasive ventilation. Eur Respir Rev 2023; 32 (167) 220159
- 45 Owusuaa C, Dijkland SA, Nieboer D, van der Rijt CCD, van der Heide A. Predictors of mortality in chronic obstructive pulmonary disease: a systematic review and meta-analysis. BMC Pulm Med 2022; 22 (01) 125
- 46 Singanayagam A, Schembri S, Chalmers JD. Predictors of mortality in hospitalized adults with acute exacerbation of chronic obstructive pulmonary disease. Ann Am Thorac Soc 2013; 10 (02) 81-89
- 47 Hardinge M, Annandale J, Bourne S. et al; British Thoracic Society Home Oxygen Guideline Development Group, British Thoracic Society Standards of Care Committee. British Thoracic Society guidelines for home oxygen use in adults. Thorax 2015; 70 (Suppl. 01) i1-i43
- 48 Jacobs SS, Krishnan JA, Lederer DJ. et al. Erratum: Home oxygen therapy for adults with chronic lung disease. An official American Thoracic Society Clinical Practice Guideline. Am J Respir Crit Care Med 2021; 203 (08) 1045-1046
- 49 Ekström M, Andersson A, Papadopoulos S. et al; REDOX Collaborative Research Group. Long-term oxygen therapy for 24 or 15 hours per day in severe hypoxemia. N Engl J Med 2024; 391 (11) 977-988
- 50 Bao H, Wang J, Zhou D. et al. Community physician-guided long-term domiciliary oxygen therapy combined with conventional therapy in stage IV COPD patients. Rehabil Nurs 2017; 42 (05) 268-273
- 51 Khor YH, Palm A, Wong AW. et al. Effects of long-term oxygen therapy on acute exacerbation and hospital burden: the national DISCOVERY study. Thorax 2025; 80 (06) 378-384
- 52 Crockett AJ, Moss JR, Cranston JM, Alpers JH. The effects of home oxygen therapy on hospital admission rates in chronic obstructive airways disease. Monaldi Arch Chest Dis 1993; 48 (05) 445-446
- 53 Dakkak J, Tang W, Smith JT. et al. Burden and unmet needs with portable oxygen in patients on long-term oxygen therapy. Ann Am Thorac Soc 2021; 18 (09) 1498-1505
- 54 Mermit Çilingir B, Günbatar H, Çilingir V. Cognitive dysfunction among patients in chronic obstructive pulmonary disease: effects of exacerbation and long-term oxygen therapy. Clin Respir J 2020; 14 (12) 1137-1143
- 55 Nishimura K, Kusunose M, Shibayama A, Nakayasu K. Is frailty a mortality predictor in subjects with chronic obstructive pulmonary disease?. Int J Chron Obstruct Pulmon Dis 2023; 18: 2955-2960
- 56 Dreher M, Neuzeret PC, Windisch W. et al. Prevalence of chronic hypercapnia in severe chronic obstructive pulmonary disease: data from the HOmeVent Registry. Int J Chron Obstruct Pulmon Dis 2019; 14: 2377-2384
- 57 Köhnlein T, Windisch W, Köhler D. et al. Non-invasive positive pressure ventilation for the treatment of severe stable chronic obstructive pulmonary disease: a prospective, multicentre, randomised, controlled clinical trial. Lancet Respir Med 2014; 2 (09) 698-705
- 58 Murphy PB, Rehal S, Arbane G. et al. Effect of home noninvasive ventilation with oxygen therapy vs oxygen therapy alone on hospital readmission or death after an acute COPD exacerbation: a randomized clinical trial. JAMA 2017; 317 (21) 2177-2186
- 59 Wilson ME, Dobler CC, Morrow AS. et al. Association of home noninvasive positive pressure ventilation with clinical outcomes in chronic obstructive pulmonary disease: a systematic review and meta-analysis. JAMA 2020; 323 (05) 455-465
- 60 Pépin JL, Herquelot E, Denis H. et al; medXcloud group. Impact of long-term non-invasive ventilation on severe exacerbations and survival in COPD: a French nationwide cohort study using multistate models. Thorax 2025; 80 (09) 616-623
- 61 Raveling T, Boersma R, Wijkstra PJ, Duiverman ML. Clinical benefit of chronic non-invasive ventilation in severe stable COPD: a matter of persistent hypercapnia improvement. Thorax 2025; 80 (04) 202-208
- 62 Ergan B, Oczkowski S, Rochwerg B. et al. European Respiratory Society guidelines on long-term home non-invasive ventilation for management of COPD. Eur Respir J 2019; 54 (03) 1901003
- 63 Macrea M, Oczkowski S, Rochwerg B. et al. Long-term noninvasive ventilation in chronic stable hypercapnic chronic obstructive pulmonary disease. An official American Thoracic Society Clinical Practice Guideline. Am J Respir Crit Care Med 2020; 202 (04) e74-e87
- 64 Pepin JL, Lemeille P, Denis H. et al; medXcloud group. Health trajectories before initiation of non-invasive ventilation for chronic obstructive pulmonary disease: a French nationwide database analysis. Lancet Reg Health Eur 2023; 34: 100717
- 65 Ambrosino N, Vitacca M, Dreher M. et al; ERS Tele-Monitoring of Ventilator-Dependent Patients Task Force. Tele-monitoring of ventilator-dependent patients: a European Respiratory Society Statement. Eur Respir J 2016; 48 (03) 648-663
- 66 Angelucci A, Aliverti A. Telemonitoring systems for respiratory patients: technological aspects. Pulmonology 2020; 26 (04) 221-232
- 67 Nagata K, Horie T, Chohnabayashi N. et al. Home high-flow nasal cannula oxygen therapy for stable hypercapnic COPD: a randomized clinical trial. Am J Respir Crit Care Med 2022; 206 (11) 1326-1335
- 68 Theunisse C, de Graaf NTC, Braam AWE. et al. The effects of home high-flow nasal cannula oxygen therapy on clinical outcomes in patients with severe COPD and frequent exacerbations. J Clin Med 2025; 14 (03) 868
- 69 Jácome C, Jácome M, Correia S. et al. Effectiveness, adherence and safety of home high flow nasal cannula in chronic respiratory disease and respiratory insufficiency: a systematic review. Arch Bronconeumol 2024; 60 (08) 490-502
- 70 Pitre T, Abbasi S, Kachkovski GV. et al. Home respiratory strategies in patients with COPD with chronic hypercapnic respiratory failure. Respir Care 2024; 69 (11) 1457-1467
- 71 Elshof J, Duiverman ML. Clinical evidence of nasal high-flow therapy in chronic obstructive pulmonary disease patients. Respiration 2020; 99 (02) 140-153
- 72 Jencks SF, Williams MV, Coleman EA. Rehospitalizations among patients in the Medicare fee-for-service program. [published correction appears in N Engl J Med. 2011 Apr 21;364(16):1582] N Engl J Med 2009; 360 (14) 1418-1428
- 73 Hansen LO, Young RS, Hinami K, Leung A, Williams MV. Interventions to reduce 30-day rehospitalization: a systematic review. Ann Intern Med 2011; 155 (08) 520-528
- 74 Stergiopoulos GM, Elayadi AN, Chen ES, Galiatsatos P. The effect of telemedicine employing telemonitoring instruments on readmissions of patients with heart failure and/or COPD: a systematic review. Front Digit Health 2024; 6: 1441334
- 75 Chauhan U, McAlister FA. Comparison of mortality and hospital readmissions among patients receiving virtual ward transitional care vs usual postdischarge care: a systematic review and meta-analysis. JAMA Netw Open 2022; 5 (06) e2219113
- 76 Vitacca M, Paneroni M, Grossetti F, Ambrosino N. Is there any additional effect of tele-assistance on long-term care programmes in hypercapnic COPD patients? A retrospective study. COPD 2016; 13 (05) 576-582
- 77 Vitacca M. Telemonitoring in patients with chronic respiratory insufficiency: expectations deluded?. Thorax 2016; 71 (04) 299-301